Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Trends in development and quality assessment of pharmaceutical formulations - F2α analogues in the glaucoma treatment
Katarzyna Asendrych-Wicik, Jakub Zarczuk, Katarzyna Walaszek, et al.
European Journal of Pharmaceutical Sciences (2022) Vol. 180, pp. 106315-106315
Open Access | Times Cited: 11

Showing 11 citing articles:

Chemical Insights into Topical Agents in Intraocular Pressure Management: From Glaucoma Etiopathology to Therapeutic Approaches
Geewoo Nam Patton, Hyuck Jin Lee
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 274-274
Open Access | Times Cited: 9
From Eye Care to Hair Growth: Bimatoprost
Marco Zeppieri, Caterina Gagliano, Leopoldo Spadea, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 561-561
Open Access | Times Cited: 5
Interaction-Based Perspective for Designing Polymer Biomaterial: A Strategic Approach to the Chitosan-Glycerophosphate System
Sougat Das, Lopamudra Giri, Saptarshi Majumdar
ACS Biomaterials Science & Engineering (2024) Vol. 10, Iss. 7, pp. 4359-4373
Closed Access | Times Cited: 4
Disclosing long-term tolerance, efficacy and penetration properties of hyaluronic acid-coated latanoprost-loaded liposomes as chronic glaucoma therapy
Marco Brugnera, Marta Vicario‐de‐la‐Torre, Miriam Ana González-Cela-Casamayor, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 730-742
Closed Access
Developing a Chromatographic Method for Quantifying Latanoprost and Related Substances in Glaucoma Treatments
Katarzyna Asendrych-Wicik, Katarzyna Malik, Magdalena Markowicz-Piasecka
Pharmaceuticals (2025) Vol. 18, Iss. 5, pp. 619-619
Open Access
The molecular aspect of anti-glaucomatous eye drops - are we harming our patients?
Anne Hedengran, Miriam Kolko
Molecular Aspects of Medicine (2023) Vol. 93, pp. 101195-101195
Closed Access | Times Cited: 7
Systemic adverse drug events to topical prostaglandin analogs for treating glaucoma: a retrospective focused pharmacovigilance study
Kannan Sridharan
BMC Ophthalmology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
The use of benzalkonium chloride in topical glaucoma treatment
Anne Nagstrup
Acta Ophthalmologica (2023) Vol. 101, Iss. S278, pp. 3-21
Open Access | Times Cited: 6
Advances in dorzolamide hydrochloride delivery: harnessing nanotechnology for enhanced ocular drug delivery in glaucoma management
Sagar R. Pardeshi, Amol D. Gholap, Navnath T. Hatvate, et al.
Discover Nano (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Case studies on adverse effects of drugs used in ocular treatment
Tyler M. Mautino, Lisa M. Himmelein, Zoe R. Phillips Connacher, et al.
Side effects of drugs annual (2024), pp. 481-490
Closed Access
Currently available prostanoids for the treatment of glaucoma and ocular hypertension: A review
Betsy Benitez, Abdelrahman M. Anter, Jennifer Arcuri, et al.
Current Opinion in Pharmacology (2023) Vol. 74, pp. 102424-102424
Closed Access | Times Cited: 1
Side effects of drugs used in ocular treatment
Tyler M. Mautino, Lisa M. Himmelein, Zoe R. Phillips Connacher, et al.
Side effects of drugs annual (2023), pp. 459-470
Closed Access
Page 1

Scroll to top